Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05ARP
|
||||
Former ID |
DAP000645
|
||||
Drug Name |
Ganciclovir
|
||||
Synonyms |
Citovirax; Cymevan; Cymeven; Cymevene; Cytovene; Ganciclovirum; Gancyclovir; HHEMG; Hydroxyacyclovir; Virgan; Vitrasert; Zirgan; GANCICLOVIR SODIUM; Ganciclovirum [Latin]; BW 759; BW 759U; Biolf 62; G 2536; GA2; IN1478; MB3795; BIOLF-62; BW-759U; BW-795; BW-B 759U; Cymevene (TN); Cytovene (TN); Cytovene-IV; DRG-0018; GCV & 1110U81; GCV & MSL; RS-21592; ST-605; Vitrasert (TN); Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; GCV
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Viral infections [ICD9: 054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053; ICD10:B01, B02, A60, B00, B27, G05.1, P35.2] | Approved | [536361] | ||
Therapeutic Class |
Antiviral Agents
|
||||
Company |
Bausch & Lomb Pharmaceuticals, Inc.
|
||||
Structure |
Download2D MOL |
||||
Formula |
C9H13N5O4
|
||||
Canonical SMILES |
C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
|
||||
InChI |
1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)
|
||||
InChIKey |
IRSCQMHQWWYFCW-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 82410-32-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
617697, 866342, 3720872, 5006228, 7298558, 7840003, 7847399, 7887702, 7979369, 8139883, 10321977, 11111224, 11111225, 11466867, 11467987, 11486454, 12013652, 14749970, 14798783, 16217245, 17405102, 23929519, 24278453, 25622077, 26758755, 29222588, 46507294, 47216865, 47515408, 47589082, 48185084, 48185085, 48334596, 48404464, 48404465, 49681203, 49698657, 49974979, 50106328, 50106329, 50113251, 53777645, 53800918, 56312143, 56312588, 56424026, 57321811, 76491727, 81041223, 85231063
|
||||
SuperDrug ATC ID |
J05AB06; S01AD09
|
||||
SuperDrug CAS ID |
cas=082410320
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | DNA polymerase | Target Info | Inhibitor | [537548] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.